FAGI.US Full Alliance Group Inc
- Market cap
- USD 435K
- P/E
- -
- P/B
- -
- ROE
- 0.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is FAGI.US undervalued?
Graham numberThe Graham number of Full Alliance Group Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Full Alliance Group Inc fundamental analysis
No fundamental analysis for Full Alliance Group Inc yet.
Full Alliance Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Full Alliance Group Inc
Full Alliance Group, Inc., through subsidiaries, engages in nutraceuticals, supplement manufacturing, health-related services, fintech, and blockchain product initiatives. The company was formerly known as Beverly Hills Group, Inc. and changed its name to Full Alliance Group, Inc. in April 2017. Full Alliance Group, Inc. was founded in 2000 and is based in Oldsmar, Florida.
Full company profileFull Alliance Group Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Full Alliance Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | - | 265K | 213K | - | - | 4.57M | 2.00M | 3.59M | 3.81M |
| Gross Profit | 0.00 | 0.00 | - | 179K | 186K | - | - | 3.91M | 1.20M | 2.98M | 2.56M |
| Operating Income | -362K | -315K | -298K | -936K | -385K | - | -8.00K | -818K | -1.82M | -198K | 331K |
| EBITDA | -362K | -315K | -298K | -764K | -179K | 237K | 220K | -757K | -1.77M | -198K | 389K |
| Net Income | -433K | -386K | -335K | -975K | -414K | -21.4K | -29.5K | -1.00M | -1.92M | -344K | 28.1K |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 138K | 127K | 40.5K | 1.56M | 1.83M | 1.83M | 1.83M | 5.10M | 5.51M | 5.79M | 5.95M |
| Total Liabilities | 1.40M | 717K | 865K | 1.40M | 1.09M | 1.10M | 1.12M | 2.46M | 1.96M | 2.37M | 2.41M |
| Shareholders' Equity | -1.26M | -590K | -824K | 164K | 740K | 727K | 704K | 2.64M | 3.11M | 3.66M | 3.67M |
| Cash & Short-term Investments | 210.00 | 157.00 | - | - | - | - | - | 1.89K | 12.8K | 98.8K | 17.5K |
| Total Debt | 1.22M | 516K | 641K | 671K | 343K | 330K | 334K | 439K | 385K | 382K | 398K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -312K | -281K | -222K | -105K | -111K | - | - | -1.37M | -1.89M | -585K | 123K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 8.00 |
| Free Cash Flow | -312K | -281K | -222K | -105K | -111K | - | - | -1.37M | -1.89M | -585K | 123K |
| Ratios | |||||||||||
| ROE | - | - | - | -594.1% | -56.0% | -2.9% | -4.2% | -38.1% | -61.7% | -9.4% | 0.8% |
| ROA | -314.4% | -303.8% | -827.2% | -62.5% | -22.7% | -1.2% | -1.6% | -19.7% | -34.8% | -5.9% | 0.5% |
| Net Profit Margin | - | - | - | -367.4% | -194.8% | - | - | -22.0% | -95.9% | -9.6% | 0.7% |
| Debt to Equity | - | - | - | 4.09x | 0.46x | 0.45x | 0.47x | 0.17x | 0.12x | 0.10x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Full Alliance Group Inc dividends
Full Alliance Group Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:100 on Oct 17, 2016.
Who owns Full Alliance Group Inc
- Insiders 0.00%
- Institutions 0.01%
- Public & others 99.99%
- Shares outstanding 136M
Full Alliance Group Inc company profile
- Company name
- Full Alliance Group Inc
- Ticker
- FAGI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 201 Douglas Rd E, Oldsmar, FL, United States, 34677
- Phone
- (800) 895-4415
- Website
- fullalliance-group.com
About Full Alliance Group Inc
Full Alliance Group, Inc., through subsidiaries, engages in nutraceuticals, supplement manufacturing, health-related services, fintech, and blockchain product initiatives. The company was formerly known as Beverly Hills Group, Inc. and changed its name to Full Alliance Group, Inc. in April 2017. Full Alliance Group, Inc. was founded in 2000 and is based in Oldsmar, Florida.
Full Alliance Group Inc management
6- Dr. Paul Brian VolppCEO, President & Director
- Mr. Rudy KisteCFO & Director
- Mr. Robert MastersonDirector of Operations & Executive Director
- Dr. Louie G. YuChief Medical Officer
- Ms. Marilyn BallVP, Secretary & Director
- Mr. Craig LanePresident of Dynamaxx Health, Inc.